Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases
Background. Yttrium-90 (Y-90) can be an effective liver-directed therapy for patients with metastatic neuroendocrine tumors (NETs), but population-based data are limited. We characterized the use of Y-90 in NET patients and identified factors associated with response. Methods. We identified 49 patie...
Main Authors: | Erica S. Tsang, Jonathan M. Loree, Janine M. Davies, Sharlene Gill, David Liu, Stephen Ho, Daniel J. Renouf, Howard J. Lim, Hagen F. Kennecke |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2020/5104082 |
Similar Items
-
Case Report of Cirrhosis following Yttrium-90 Radioembolization for Pancreatic Neuroendocrine Liver Metastases
by: Jonathan M. Loree, et al.
Published: (2016-01-01) -
Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
by: Raval eMihir, et al.
Published: (2014-07-01) -
Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer
by: Alexander C. Bunck, et al.
Published: (2017-07-01) -
Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
by: Ron C. Gaba, et al.
Published: (2012-08-01) -
Radioembolization and the dynamic role of 90Y PET/CT
by: Alexander S Pasciak, et al.
Published: (2014-02-01)